Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-511X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study ; volume:16 ; number:1 ; day:24 ; month:7 ; year:2017 ; pages:1-11 ; date:12.2017
Lipids in health and disease ; 16, Heft 1 (24.7.2017), 1-11, 12.2017
- Creator
-
Choi, Joshua
- Contributor
-
Khan, Amir M.
Jarmin, Michael
Goldenberg, Naila
Glueck, Charles J.
Wang, Ping
SpringerLink (Online service)
- DOI
-
10.1186/s12944-017-0493-7
- URN
-
urn:nbn:de:1111-201708311429
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:38 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Choi, Joshua
- Khan, Amir M.
- Jarmin, Michael
- Goldenberg, Naila
- Glueck, Charles J.
- Wang, Ping
- SpringerLink (Online service)